Mucinous Prostate Cancer Shows Similar Prognosis to Typical Prostate Acinar Carcinoma: A Large Population-Based and Propensity Score-Matched Study
Open Access
- 9 January 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 9, 1467
- https://doi.org/10.3389/fonc.2019.01467
Abstract
Background: Mucinous prostate cancer (PCa) is an extremely rare form of prostate malignancy. To date, the limited knowledge of its biology and outcomes stems from mostly small, single institution experiences. We analyzed the Surveillance, Epidemiology, and End Results (SEER) database to explore the incidence and treatment of mucinous PCa together with its prognostic factors to gain relatively large and consolidated insights. Methods: Age-adjusted incidence (AAI) rates were evaluated over time. Propensity score matching (PSM) and Kaplan–Meier analyses were used to compare the prognosis between mucinous PCa and typical prostate acinar adenocarcinoma. We assessed cancer-specific survival (CSS) and overall survival (OS) after patient stratification according to summary stage and treatment choice. Cox hazards regression analysis was performed to determine independent predictors of CSS and OS. Results: The AAI in 2016 was 0.24 per million. Patients with mucinous PCa had similar CSS and OS to matched individuals with typical prostate acinar adenocarcinoma. In terms of treatment, 65.3% of mucinous PCa patients underwent surgery, and 23.9% received radiation therapy. Patients who underwent surgery had longer survival (CSS, p = 0.012; OS, p < 0.001), and patients who received radiation therapy had similar survival to those who did not receive radiation therapy (CSS, p = 0.794; OS, p = 0.097). A multivariate Cox analysis for CSS and OS showed that older age (CSS: HR: 4.982, p = 0.001; OS: HR: 4.258, p < 0.001) and distant stage (CSS: HR: 40.224, p < 0.001; OS: HR: 9.866, p < 0.001) were independent prognostic factors for mucinous PCa patients. Conclusions: Mucinous PCa has an extremely low AAI. Analysis of its outcomes indicates that it is not a more malignant tumor as previously suspected. Mucinous PCa shows a similar prognosis to typical prostate acinar carcinoma. Surgery was associated with prolonged survival. An older age at diagnosis and distant stage was associated with poor survival.Funding Information
- National Natural Science Foundation of China (81701683)
This publication has 21 references indexed in Scilit:
- The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic CarcinomaThe American Journal of Surgical Pathology, 2016
- Prostate cancer in young men: an important clinical entityNature Reviews Urology, 2014
- Prostate Mucinous Carcinoma Treated With Definitive Radiotherapy and Hormonal Therapy: Case Report and Review of the LiteratureClinical Genitourinary Cancer, 2014
- ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: comparison with conventional prostatic adenocarcinomaHuman Pathology, 2013
- Morphological characteristics of a mucinous adenocarcinoma of the prostate: differential diagnosis considerations.2013
- A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008Prostate Cancer and Prostatic Diseases, 2012
- Prognosis of Mucinous Adenocarcinoma of the Prostate Treated by Radical ProstatectomyThe American Journal of Surgical Pathology, 2008
- Mucinous adenocarcinoma of the prostate: a case report of long-term disease-free survival and a review of the literatureUrology, 2004
- Unusual subtypes of prostate cancerLaboratory Investigation, 2004
- Mucinous adenocarcinoma of prostateUrology, 1989